Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT01476410||Active, not recruiting||Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma||
||Other / Industry||
||48||All||60 Years and older (Adult, Senior)||NCT01476410||NU 11H01
|November 2011||May 2018||May 2019||November 22, 2011||February 5, 2018||